Concepedia

Philip M. Sher

PM

Statistics

Publications

13

Citations

1.4K

H-Index

12

Active since

1983

Affiliations

Bristol-Myers Squibb (United States)(Current)

Philip M. Sher is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1983–2017

13

Publications

13

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Wei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl et al. · Journal of Medicinal Chemistry · 2008 · 628 citations · Full text

, , +17

A catalytic tin system for trapping of radicals from cyclization reactions. Regio- and stereocontrolled formation of two adjacent chiral centers

Gilbert Stork, Philip M. Sher · Journal of the American Chemical Society · 1986 · 253 citations

, , +6

Radical cyclization-trapping in the synthesis of natural products. A simple, stereocontrolled route to prostaglandin F2.alpha.

Gilbert Stork, Philip M. Sher, Hai Lin. Chen · Journal of the American Chemical Society · 1986 · 157 citations

, , +9

Regiospecific trapping of radicals from cyclization reactions. Cyclic nitriles via isocyanide trapping

Gilbert Stork, Philip M. Sher · Journal of the American Chemical Society · 1983 · 134 citations

, , +6

Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2

Bruce A. Ellsworth, Wei Meng, Manorama M. Patel et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 57 citations · Full text

, , +13

1–5 of 13